Cannabis to be Assessed as an Alternative to Fentanyl in Pivotal Clinical Trial
The trial is designed to assess the time-to-relief in patients suffering from severe pain.
DEA Green-lights Novel Cannabinoid Research
The research will build on previous findings that could enhance the performance of other cancer therapeutics such as checkpoint inhibitors, which activate the immune system to destroy cancer cells.
Enhancing the Bioavailability of Cannabinoids
Researchers are striving to develop a full-profile, non-psychoactive cannabis extract product to help meet unmet medical needs.
Supra THC Obtains ISO 17025 Accreditation
Securing testing results from an ISO 17025 accredited laboratory is the best way for cannabis producers to ensure that they are producing high-quality, safe products.
Cannabis Does Not Increase Suicidal Behavior In Psychiatric Patients
Recent findings contrast with pre-existing data that shows the drug is linked to an increased chance of suicidal behaviour in the general population.
Quadron Expands Product Range to Capitalize on Extracts
While cannabis flower characterized the market in the early years, cannabis extracts have become increasingly popular and eclipsed cannabis flower sales this year.
Aurora Acquires Anandia Labs for $115M
Anandia plans to accelerate their current breeding efforts to create the next-generation of cannabis plants and, expand their testing capabilities.
A Big Step Forward for Medical Marijuana
Medical marijuana has picked up considerable momentum after a U.S. FDA advisory panel unanimously recommended approval of GW Pharmaceuticals' epilepsy medication, Epidolex.
Multiple Sclerosis Study Could Push Cannabis Compounds Closer to FDA Approval
MMJ is seeking to scientifically assess and prove the effectiveness of their THC/CBD compounds treating and preventing symptoms associated with multiple sclerosis.
